Sobi and Selecta Biosciences complete enrolment for gout therapy trial
The DISSOLVE I study will assess the efficacy and safety of SEL-212 to treat chronic refractory gout.
Sweden
Latest in
Sweden
InDex begins enrolment in trial of cobitolimod to treat ulcerative colitis
The Phase III CONCLUDE clinical trial will recruit nearly 440 patients at several clinics in more than 30 countries.
Trialbee unveils centralised clinical trial patient recruitment platform
Trialbee Honey helps in recruiting and engaging qualified patients for a clinical study.
BioInvent enters partnership for combination therapy of solid tumours
This is BioInvent’s second deal for Merck’s Keytruda as a combination treatment for cancer patients.
Worldwide Clinical Trials and Trialbee partner to boost enrolment
Worldwide Clinical Trials partners with Trialbee to bolster patient enrolment and streamline timelines for clinical trials.
Apellis and Sobi’s Empaveli yields positive Phase III data in PNH
Apellis and Sobi’s Phase III PRINCE trial of Empaveli meets primary endpoints in paroxysmal nocturnal haemoglobinuria patients.
Vicore Pharma’s oral C21 provides clinical improvement in Covid-19 trial
Vicore Pharma has announced positive top-line data from the Angiotensin II Type Two Receptor Agonist Covid-19 Trial (ATTRACT) study of…
Swedish trial to assess prostate cancer drug for Covid-19
Swedish researchers have announced a new clinical trial to assess a prostate cancer drug, called Enzalutamide, for the treatment of…